COEPTIS’ NexGenAI Affiliates Partners with NUBURU Network to Drive Innovation in AI and Robotics as Part of its Transformation Plan
COEPTIS (Nasdaq: COEP) has announced a strategic partnership between its NexGenAI Affiliates Network (NexGen) and NUBURU (NYSE: BURU), a blue laser technology company. The collaboration is part of NUBURU's Transformation Plan, led by Executive Chairman Alessandro Zamboni, focusing on defense-tech, security, and operational resilience solutions.
NexGen will support NUBURU by implementing AI-driven capabilities and robotic process automation to enhance marketing strategies and B2B sales processes, particularly in the defense and security sector. NUBURU aims to leverage its laser-technology expertise and recent investments to enable growth across its subsidiaries and strategic ventures.
The partnership will utilize NexGen's advanced platform, which employs AI algorithms and data analytics to optimize marketing strategies and enhance customer engagement. NUBURU's strategy involves positioning itself as a blitz-scaling enabler through the adoption of exponential technologies.
COEPTIS (Nasdaq: COEP) ha annunciato una partnership strategica tra la sua NexGenAI Affiliates Network (NexGen) e NUBURU (NYSE: BURU), un'azienda specializzata in tecnologia laser blu. La collaborazione fa parte del Piano di Trasformazione di NUBURU, guidato dal Presidente Esecutivo Alessandro Zamboni, che si concentra su soluzioni per la difesa, la sicurezza e la resilienza operativa.
NexGen supporterà NUBURU implementando capacità guidate dall'IA e automazione dei processi robotici per migliorare le strategie di marketing e i processi di vendita B2B, in particolare nel settore della difesa e della sicurezza. NUBURU mira a sfruttare la sua esperienza nella tecnologia laser e gli investimenti recenti per abilitare la crescita delle sue filiali e delle sue iniziative strategiche.
La partnership utilizzerà la piattaforma avanzata di NexGen, che impiega algoritmi di IA e analisi dei dati per ottimizzare le strategie di marketing e migliorare l'engagement dei clienti. La strategia di NUBURU prevede di posizionarsi come un abilitante dello scaling rapido attraverso l'adozione di tecnologie esponenziali.
COEPTIS (Nasdaq: COEP) ha anunciado una asociación estratégica entre su NexGenAI Affiliates Network (NexGen) y NUBURU (NYSE: BURU), una empresa de tecnología de láser azul. La colaboración es parte del Plan de Transformación de NUBURU, liderado por el Presidente Ejecutivo Alessandro Zamboni, que se enfoca en soluciones de defensa, seguridad y resiliencia operativa.
NexGen apoyará a NUBURU implementando capacidades impulsadas por IA y automatización de procesos robóticos para mejorar las estrategias de marketing y los procesos de ventas B2B, particularmente en el sector de defensa y seguridad. NUBURU busca aprovechar su experiencia en tecnología láser y las inversiones recientes para permitir el crecimiento a través de sus subsidiarias y empresas estratégicas.
La asociación utilizará la plataforma avanzada de NexGen, que emplea algoritmos de IA y análisis de datos para optimizar las estrategias de marketing y mejorar el compromiso del cliente. La estrategia de NUBURU implica posicionarse como un habilitador de escalado rápido a través de la adopción de tecnologías exponenciales.
COEPTIS (Nasdaq: COEP)는 NexGenAI Affiliates Network(NexGen)와 NUBURU (NYSE: BURU) 간의 전략적 파트너십을 발표했습니다. NUBURU의 변혁 계획의 일환으로, 이 계획은 알레산드로 잠보니(Alessandro Zamboni) 회장이 주도하며 방위 기술, 보안 및 운영 회복력 솔루션에 중점을 두고 있습니다.
NexGen은 방위 및 보안 부문에서 마케팅 전략과 B2B 판매 프로세스를 향상시키기 위해 AI 기반 기능과 로봇 프로세스 자동화를 구현하여 NUBURU를 지원할 것입니다. NUBURU는 레이저 기술 전문성과 최근 투자들을 활용하여 자회사 및 전략적 벤처의 성장을 도모할 계획입니다.
파트너십은 마케팅 전략을 최적화하고 고객 참여를 향상시키기 위해 AI 알고리즘과 데이터 분석을 사용하는 NexGen의 고급 플랫폼을 활용할 것입니다. NUBURU의 전략은 기하급수적 기술의 도입을 통해 블리츠 스케일링을 가능하게 하는 것입니다.
COEPTIS (Nasdaq: COEP) a annoncé un partenariat stratégique entre son NexGenAI Affiliates Network (NexGen) et NUBURU (NYSE: BURU), une entreprise spécialisée dans la technologie des lasers bleus. La collaboration fait partie du Plan de Transformation de NUBURU, dirigé par le Président Exécutif Alessandro Zamboni, axé sur des solutions de défense, de sécurité et de résilience opérationnelle.
NexGen soutiendra NUBURU en mettant en œuvre des capacités basées sur l'IA et l'automatisation des processus robotiques pour améliorer les stratégies marketing et les processus de vente B2B, en particulier dans le secteur de la défense et de la sécurité. NUBURU vise à tirer parti de son expertise en technologie laser et des investissements récents pour favoriser la croissance de ses filiales et de ses initiatives stratégiques.
Le partenariat utilisera la plateforme avancée de NexGen, qui emploie des algorithmes d'IA et des analyses de données pour optimiser les stratégies marketing et améliorer l'engagement client. La stratégie de NUBURU consiste à se positionner comme un facilitateur de blitz-scaling grâce à l'adoption de technologies exponentielles.
COEPTIS (Nasdaq: COEP) hat eine strategische Partnerschaft zwischen seinem NexGenAI Affiliates Network (NexGen) und NUBURU (NYSE: BURU), einem Unternehmen für blaue Lasertechnologie, angekündigt. Die Zusammenarbeit ist Teil des Transformationsplans von NUBURU, der vom Executive Chairman Alessandro Zamboni geleitet wird und sich auf Lösungen für Verteidigung, Sicherheit und operationale Resilienz konzentriert.
NexGen wird NUBURU unterstützen, indem es KI-gesteuerte Fähigkeiten und robotergestützte Prozessautomatisierung implementiert, um Marketingstrategien und B2B-Verkaufsprozesse, insbesondere im Verteidigungs- und Sicherheitssektor, zu verbessern. NUBURU möchte seine Expertise in Lasertechnologie und die jüngsten Investitionen nutzen, um das Wachstum seiner Tochtergesellschaften und strategischen Ventures zu ermöglichen.
Die Partnerschaft wird die fortschrittliche Plattform von NexGen nutzen, die KI-Algorithmen und Datenanalysen einsetzt, um Marketingstrategien zu optimieren und das Kundenengagement zu verbessern. Die Strategie von NUBURU besteht darin, sich als Blitzskalierungs-Enabler zu positionieren, indem exponentielle Technologien übernommen werden.
- Strategic expansion into defense and security sectors
- Integration of advanced AI and automation capabilities
- Potential for new revenue streams through technology synergies
- No immediate financial impact disclosed
- Implementation timeline and costs not specified
- Success depends on unproven transformation strategy
Insights
COEPTIS' partnership with NUBURU represents a strategic alignment between the company's NexGenAI Affiliates Network and NUBURU's blue laser technology, specifically targeting applications in defense and security sectors. While the announcement positions this as a significant development, the partnership appears primarily focused on marketing strategy enhancement rather than direct product integration or revenue-generating activities.
The collaboration fundamentally centers on COEPTIS providing AI-driven capabilities and robotic process automation to assist NUBURU's transformation plan. However, the announcement lacks critical details regarding financial terms, revenue projections, or specific implementation timelines that would help assess tangible impact on COEPTIS' future performance.
This partnership signals COEPTIS' continued pivot toward technology diversification beyond its biotechnology foundation, potentially opening new market opportunities in the defense sector. However, investors should note the preliminary nature of this announcement, with benefits described in aspirational terms rather than concrete deliverables. The emphasis on "anticipated" roles and "future redesigned" processes suggests this partnership remains in early planning stages.
While strategically promising, particularly in connecting COEPTIS to defense applications, the material impact on near-term financial performance remains unclear without quantifiable metrics or defined project milestones.
Leveraging Advanced AI and Robotics to Revolutionize Marketing Strategies in Defense and Security Sectors
WEXFORD, Pa., March 07, 2025 (GLOBE NEWSWIRE) -- COEPTIS, Inc. (Nasdaq: COEP) ("the Company" or "COEPTIS"), a pioneering technology firm at the forefront of innovative biotechnology solutions today announced its strategic partnership with COEPTIS’ NexGenAI Affiliates Network “NexGen” and NUBURU, Inc. “NUBURU” (NYSE: BURU), a leading innovator in high-power blue laser technology. This collaboration is a pivotal component of COEPTIS’ strategic position in technology and Artificial Intelligence and NUBURU’s comprehensive Transformation Plan, spearheaded by Executive Chairman Alessandro Zamboni, aimed at enhancing operational efficiency and revamping the company’s business model entering defense-tech, security, and operational resilience solutions.
NexGen will be assisting NUBURU in its Transformation Plan by using its cutting-edge AI-driven capabilities and robotic process automation. NUBURU is anticipated to play an important role as a tech and business growth enabler of its subsidiaries and the other strategic ventures and investments leveraging the existing know-how regarding blue-laser technology and additional expertise to be brought by their new management team.
Dave Mehalick, CEO of COEPTIS stated, “Partnering with NUBURU marks a significant step in COEPTIS' journey toward pioneering innovative technology solutions. By harnessing the power of NexGen’s AI-driven capabilities, we are poised to not only enhance our own operational efficiencies but also redefine how businesses engage with their clients in the rapidly evolving defense and security landscape. This collaboration underscores our commitment to fostering growth through advanced technological integrations.”
The partnership between NexGen and NUBURU exemplifies NUBURU’s strategy to revolutionize its planned marketing and B2B sales processes, particularly within the defense and security sector, where the company anticipates significant opportunities for growth leveraging its laser-technology expertise and experience and recently announced investments.
Alessandro Zamboni Executive Chairman of NUBURU stated, “Our partnership with COEPTIS’ NexGenAI Affiliates Network is an exciting step forward in executing our Transformation Plan. By integrating cutting-edge AI-driven capabilities and robotic process automation into our future redesigned marketing & sales processes, we are not only streamlining our business but also creating a foundation for an innovative business model. This strategic collaboration aligns perfectly with our vision of establishing synergies across our acquisitions and enhancing our market presence in the defense and security sectors, where our laser-technology expertise can play an important role”.
NexGen’s advanced platform utilizes sophisticated AI algorithms and data analytics to optimize marketing strategies, enhance customer engagement, and implement operational efficiencies. This collaboration marks an essential milestone in NUBURU's broader goal of fostering an ecosystem where technology serves as a catalyst for growth and innovation.
“Incorporating NexGen's transformative technologies will allow us to elevate our future marketing strategies as we implement or Transformation Plan,” added Zamboni. “We believe that by positioning NUBURU as a blitz-scaling enabler of its anticipated business lines, by leveraging the adoption of exponential technologies, we can significantly enhance our value proposition to future end-clients and stakeholders alike.”
About COEPTIS, Inc.
COEPTIS, Inc., together with its subsidiaries Coeptis Pharmaceuticals, Inc., GEAR Therapeutics, Inc., SNAP Biosciences, Inc., and Coeptis Technologies (collectively "Coeptis"), is a biopharmaceutical and technology company. The biopharmaceutical divisions focus on developing innovative cell therapy platforms for cancer, autoimmune, and infectious diseases. Coeptis aims to advance treatment paradigms and improve patient outcomes through its cutting-edge research and development efforts.
The Company's therapeutic portfolio is underscored by assets licensed from Deverra Therapeutics, which include an allogeneic cellular immunotherapy platform and DVX201, a clinical-stage, unmodified natural killer cell therapy technology. COEPTIS is also developing a universal, multi-antigen CAR technology licensed from the University of Pittsburgh (SNAP-CAR), alongside GEAR cell therapy and companion diagnostic platforms in collaboration with VyGen-Bio and distinguished medical researchers at the Karolinska Institute.
Building on its core competencies, COEPTIS has recently established a Technology Division, which focuses on enhancing operational capabilities through advanced technologies. This division features AI-powered marketing software and robotic process automation tools acquired from NexGenAI Solutions Group, designed to optimize business processes and improve overall efficiency.
Headquartered in Wexford, PA, COEPTIS is dedicated to advancing its mission within the regulatory framework set forth by the FDA, ensuring that all activities align with the highest standards of compliance and patient care. For more information on COEPTIS, visit https://coeptistx.com
About NexGenAI Affiliates Network
NexGenAI Affiliates Network is a state-of-the-art AI-powered affiliate marketing platform designed to streamline marketing efforts through automation and advanced analytics. Owned by COEPTIS, Inc. (NASDAQ: COEP), NexGenAI Affiliates Network empowers individuals and businesses to optimize their affiliate campaigns and maximize revenue through AI-driven content distribution, automated email outreach, and social media integration. For more information on this partnership and how it can benefit businesses and affiliates, visit https://nexgenaiaffiliates.io/.
About NUBURU
NUBURU, Inc. was founded in 2015 as a developer and manufacturer of industrial blue laser technology that is transforming the speed and quality of laser-based manufacturing. Under its new management team led by Executive Chairman Alessandro Zamboni, NUBURU is executing a comprehensive growth and diversification strategy, expanding into complementary domains such as defense-tech, security, and operational resilience solutions. Headquartered in Centennial, Colorado, NUBURU is leveraging strategic partnerships and acquisitions to accelerate growth in high-value sectors. For more information, visit www.nuburu.net.
Cautionary Note Regarding Forward-Looking Statements
This press release and statements of our management made in connection therewith contain or may contain "forward-looking statements" (as defined in Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of
1934, as amended). Forward-looking statements include statements concerning our plans, objectives, goals, strategies, future events or performance, and underlying assumptions, and other statements that are other than statements of historical facts. When we use words such as "may," "will," "intend," "should," "believe," "expect," "anticipate," "project," "estimate" or similar expressions that do not relate solely to historical matters, we are making forward-looking statements. Forward-looking statements are not a guarantee of future performance and involve significant risks and uncertainties that may cause the actual results to differ materially and perhaps substantially from our expectations discussed in the forward-looking statements. Factors that may cause such differences include but are not limited to: (1) the inability to maintain the listing of the Company's securities on the Nasdaq Capital Market; (2) the inability to recognize the anticipated benefits of the Deverra licensed assets, which may be affected by, among other things, competition, the ability of the Company to grow and manage growth economically and hire and retain key employees; (3) the risks that the Company's products in development or the newly-licensed assets fail clinical trials or are not approved by the U.S. Food and Drug Administration or other applicable regulatory authorities; (4) costs related to ongoing asset development including the Deverra licensed assets and pursuing the contemplated asset development paths; (5) changes in applicable laws or regulations; (6) the possibility that the Company may be adversely affected by other economic, business, and/or competitive factors; and (7) the impact of the global COVID-19 pandemic on any of the foregoing risks and other risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission (the "SEC"). The foregoing list of factors is not exclusive. All forward-looking statements are subject to significant uncertainties and risks including, but not limited, to those risks contained or to be contained in reports and other filings filed by the Company with the SEC. For these reasons, among others, investors are cautioned not to place undue reliance upon any forward-looking statements in this press release. Additional factors are discussed in the Company's filings made or to be made with the SEC, which are available for review at www.sec.gov. We undertake no obligation to publicly revise these forward-looking statements to reflect events or circumstances that arise after the date hereof unless required by applicable laws, regulations, or rules.
Contacts
COEPTIS, INC. (NASDAQ: COEP)
Investor Relations: IR@coeptistx.com
Website: https://coeptistx.com
NexGenAI Affiliates Network: https://nexgenaiaffiliates.io
NUBURU, Inc. (NYSE: BURU)
Investor Relations: alessandro.zamboni@nuburu.net
Media Contact: press@nuburu.net
Website: www.nuburu.net
FAQ
What is the strategic partnership between COEP and NUBURU focused on?
How will NexGen's AI technology benefit NUBURU's transformation plan?
What is NUBURU's new strategic direction under the transformation plan?
How does this partnership affect COEP's technology strategy?
